289 related articles for article (PubMed ID: 31604528)
1. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA.
Bo C; Li X; He L; Zhang S; Li N; An Y
Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528
[TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
3. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
4. Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2.
Yang Y; Cheng Y; Mou Y; Tang X; Mu X
Crit Rev Eukaryot Gene Expr; 2022; 33(1):67-77. PubMed ID: 36374812
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
7. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
Bo C; Li N; He L; Zhang S; An Y
Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ALKBH3-AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion.
Lu Q; Wang H; Lei X; Ma Q; Zhao J; Sun W; Guo C; Huang D; Xu Q
J Cell Mol Med; 2022 Oct; 26(20):5292-5302. PubMed ID: 36098205
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A.
He J; Yu J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696213
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
Luo X; Zhou N; Wang L; Zeng Q; Tang H
Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.
Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X
Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma.
Sheng N; Li Y; Qian R; Li Y
Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973
[TBL] [Abstract][Full Text] [Related]
19. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
